PharmaShots Interview: Prothena’s Brandon Smith Shares Insight on the Acquisition of Prothena and Novo Nordisk
In an interview with PharmaShots, Brandon Smith, Chief Business Officer at Prothena shared his views on Novo Nordisk’s acquisition of Prothena’s ATTR amyloidosis program includes PRX004 Shots: The companies have […]